BioCryst Pharmaceuticals, Inc. earnings per share and revenue

BCRX earnings per share for the last quarter are -0.31 USD whereas the estimation was -0.25 USD which accounts for -26.08% surprise. Företagets omsättning för samma period uppgår till 93.40 M USD trots den uppskattade siffran 89.97 M USD. Estimated earnings per share for the next quarter are -0.21 USD, and revenue is expected to reach 85.62 M USD. Also watch annual changes over time to get a bigger picture of BCRX earnings per share and revenue dynamics.